Macrophages associated with tumors as potential targets and therapeutic intermediates

Nanomedicine

Volumn 9, Issue 5, 2014, Pages 695-707

  Vinogradov, Serguei ^a   Warren, Galya ^a   Wei, Xin ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

'Trojan horses'; biodistribution of nanoparticles; cancer stem cell; eradication of cancer cells; macrophage; nanocarrier; phagocytosis; reprogramming of macrophages; tumor associated macrophage; tumor supporting function

Indexed keywords

GOLD NANOPARTICLE; HEMOGLOBIN; LIPOSOME; MANNOSE OLIGOSACCHARIDE; NANOCARRIER; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; ANTINEOPLASTIC AGENT; NANOCAPSULE;

CANCER CELL DESTRUCTION; CARCINOGENESIS; DRUG TARGETING; IN VITRO STUDY; METASTASIS; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; REVIEW; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; ANIMAL; CELL COMMUNICATION; CHEMISTRY; DRUG EFFECTS; DRUG FORMULATION; HUMAN; IMMUNOLOGY; MACROPHAGE; NEOPLASMS; PATHOLOGY; PROCEDURES; ULTRASTRUCTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL COMMUNICATION; DRUG COMPOUNDING; HUMANS; MACROPHAGES; NANOCAPSULES; NEOPLASMS;

EID: 84901048028     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.14.13     Document Type: Review

References (81)

1. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4(1), 71-78 (2004
2. Solinas G, Germano G, MantoVani A, Allavena P. Tumorassociated macrophages (TAM) as major players of the cancerrelated inflammation. J. Leukoc. Biol. 86(5), 1065-1073 (2009
3. Bingle L, Brown NJ, Lewis CE. The role of tumour-Associated macrophages in tumour progression: Implications for new anticancer therapies. J. Pathol. 196(3), 254-265 (2002
4. Peddareddigari VG, Wang D, Dubois RN. The tumor microenvironment in colorectal carcinogenesis. Cancer Microenviron. 3(1), 149-166 (2010
5. Wang R, Lu M, Zhang J et al. Increased IL-10 mRNA expression in tumor-Associated macrophage correlated with late stage of lung cancer. J. Exp. Clin. Cancer Res. 30, 62 (2011
6. Lin EY, Pollard JW. Tumor-Associated macrophages press the angiogenic switch in breast cancer. Cancer Res. 67(11), 5064-5066 (2007
7. MantoVani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: Tumor-Associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23(11), 549-555 (2002
8. Benson DD, Meng X, Fullerton DA et al. Activation state of stromal inflammatory cells in murine metastatic pancreatic adenocarcinoma. Am. J. Physiol. Regul. Integr. Comp. Physiol. 302(9), R1067-R1075 (2012
9. Mielgo A, Schmid MC. Impact of tumour associated macrophages in pancreatic cancer. BMB Rep. 46(3), 131-138 (2013
10. Wang B, Li Q, Qin L, Zhao S, Wang J, Chen X. Transition of tumor-Associated macrophages from MHC class II(hi) to MHC class II(low) mediates tumor progression in mice. BMC Immunol. 12, 43 (2011
11. Cortez-Retamozo V, Etzrodt M, Newton A et al. Origins of tumor-Associated macrophages and neutrophils. Proc. Natl Acad. Sci. USA 109(7), 2491-2496 (2012
12. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147 (1999
13. Karnoub AE, Dash AB, Vo AP et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449(7162), 557-553 (2007
14. Smith HA, Kang Y. The metastasis-promoting roles of tumorassociated immune cells. J. Mol. Med. (Berl.) 91(4), 411-429 (2013
15. Sica A, Schioppa T, MantoVani A, Allavena P. Tumourassociated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy. Eur. J. Cancer 42(6), 717-727 (2006
16. Jinushi M, Chiba S, Yoshiyama H et al. Tumor-Associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells. Proc. Natl Acad. Sci. USA 108(30), 12425-12430 (2011
17. Yang J, Liao D, Chen C et al. Tumor-Associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/STET3/Sox-2 signaling pathway. Stem Cells 31(2), 248-258 (2013
18. Ye XZ, Xu SL, Xin YH et al. Tumor-Associated microglia/ macrophages enhance the invasion of glioma stem-like cells via TGF-β1 signaling pathway. J. Immunol. 189(1), 444-453 (2012
19. Guo S, Dipietro LA. Factors affecting wound healing. J. Dent. Res. 89(3), 219-229 (2010
20. Daldrup-Link HE, Golovko D, Ruffell B et al. MRI of tumor-Associated macrophages with clinically applicable iron oxide nanoparticles. Clin. Cancer Res. 17(17), 5695-5704 (2011
21. De Palma M, Lewis CE. Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell 23(3), 277-286 (2013
22. Madsen SJ, Baek SK, Makkouk AR, Krasieva T, Hirschberg H. Macrophages as cell-based delivery systems for nanoshells in photothermal therapy. Ann. Biomed. Eng. 40(2), 507-515 (2012
23. Choi MR, Stanton-Maxey KJ, Stanley JK et alA cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors. Nano Lett. 7(12), 3759-3765 (2007
24. Yang TD, Choi W, Yoon TH et al. Real-Time phase-contrast imaging of photothermal treatment of head and neck squamous cell carcinoma: An in vitro study of macrophages as a vector for the delivery of gold nanoshells. J. Biomed. Opt. 17(12), 128003 (2012
25. Dreaden EC, Mwakwari SC, Austin LA, Kieffer MJ, Oyelere AK, El-Sayed MA. Small molecule-gold nanorod conjugates selectively target and induce macrophage cytotoxicity towards breast cancer cells. Small 8(18), 2819-2822 (2012
26. Wang H, Shrestha TB, Basel MT et al. Magnetic-Fe/Fe(3) O(4)-nanoparticle-bound SN38 as carboxylesterase-cleavable prodrug for the delivery to tumors within monocytes/ macrophages. Beilstein J. Nanotechnol. 3, 444-455 (2012
27. Shrivastava P, Singh SM, Singh N. Effect of thymosin alpha 1 on the antitumor activity of tumor-Associated macrophagederived dendritic cells. J. Biomed. Sci. 11(5), 623-630 (2004
28. Ikehara Y, Niwa T, Biao L et al. A carbohydrate recognitionbased drug delivery and controlled release system using intraperitoneal macrophages as a cellular vehicle. Cancer Res. 66(17), 8740-8748 (2006
29. Yu SS, Lau CM, Barham WJ et al. Macrophage-specific RNA interference targeting via 'click', mannosylated polymeric micelles. Mol. Pharm. 10(3), 975-987 (2013
30. Lin AY, Almeida JP, Bear A et al. Gold nanoparticle delivery of modified CpG stimulates macrophages and inhibits tumor growth for enhanced immunotherapy. PLoS ONE 8(5), e63550 (2013
31. Zhang N, Palmer AF. Liposomes surface conjugated with human hemoglobin target delivery to macrophages. Biotechnol. Bioeng. 109(3), 823-829 (2012
32. Akao Y, Iio A, Itoh T et al. Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages. Mol. Ther. 19(2), 395-399 (2011
33. Holden CA, Yuan Q, Yeudall WA, Lebman DA, Yang H. Surface engineering of macrophages with nanoparticles to generate a cell-nanoparticle hybrid vehicle for hypoxiatargeted drug delivery. Int. J. Nanomed. 5, 25-36 (2010
34. He C, Hu Y, Yin L, Tang C, Yin C. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31(13), 3657-3666 (2010
35. Gratton SE, Ropp PA, Pohlhaus PD et al. The effect of particle design on cellular internalization pathways. Proc. Natl Acad. Sci. USA 105(33), 11613-11618 (2008
36. Gerson T, Makarov E, Gorantla S, Senanayake T, Poluektova LV, Vinogradov SV. Nano-NRTIs demonstrate low neurotoxicity and high antiviral activity against HIV infection in the brain. Nanomedicine 10(1), 177-185 (2014
37. Wan L, Zhang X, Pooyan S et al. Optimizing size and copy number for PEG-fMLF (N-formyl-methionyl-leucylphenylalanine) nanocarrier uptake by macrophages. Bioconjug. Chem. 19(1), 28-38 (2008
38. Nowacek AS, Miller RL, Mcmillan J et al. NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery. Nanomedicine (Lond.) 4(8), 903-917 (2009
39. Dash PK, Gendelman HE, Roy U et al. Long-Acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice. AIDS 26(17), 2135-2144 (2012
40. Haney MJ, Suresh P, Zhao Y et al. Blood-borne macrophage-neural cell interactions hitchhike on endosome networks for cell-based nanozyme brain delivery. Nanomedicine (Lond.) 7(6), 815-833 (2012
41. Haney MJ, Zhao Y, Harrison EB et al. Specific transfection of inflamed brain by macrophages: A new therapeutic strategy for neurodegenerative diseases. PLoS ONE 8(4), e61852 (2013
42. Hirota K, Hasegawa T, Nakajima T et al. Delivery of rifampicin-PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis. J. Control. Release 142(3), 339-346 (2010
43. Brown DM, Kinloch IA, Bangert U et al. An in vitro study of the potential of carbon nanotubes and nanofibres to induce inflammatory mediators and frustrated phagocytosis. Carbon 45(9), 1743-1756 (2007
44. Hiraoka K, Zenmyo M, Watari K et al. Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages. Cancer Sci. 99, 1595-1602 (2008
45. Wels J, Kaplan RN, Rafii S, Lyden D. Migratory neighbors and distant invaders: Tumor-Associated niche cells. Genes Dev. 22(5), 559-574 (2008
46. Ding J, Jin W, Chen C, Shao Z, Wu J. Tumor associated macrophage ' cancer cell hybrids may acquire cancer stem cell properties in breast cancer. PLoS ONE 7(7), e41942 (2012
47. Dittmar T, Nagler C, Niggemann B, Zänker KS. The dark side of stem cells: Triggering cancer progression by cell fusion. Curr. Mol. Med. 13(5), 735-750 (2013
48. Owens DE 3rd, Peppas NA. Opsonisation, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 307(1), 93-102 (2006
49. Walkey CD, Olsen JB, Guo H, Emili A, Chan WC. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J. Am. Chem. Soc. 134(4), 2139-2147 (2012
50. Skoczen SL, Potter TM, Dobrovolskaia MA. In vitro analysis of nanoparticle uptake by macrophages using chemiluminescence. Methods Mol. Biol. 697, 255-261 (2011
51. Weissleder R, Kelly K, Sun EY, Shtatland T, Josephson L. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat. Biotechnol. 23(11), 1418-1423 (2005
52. Vinogradov SV. Nanogels in the race for drug delivery. Nanomedicine (Lond.) 5(2), 165-168 (2010
53. Yang SH, Heo D, Park J et al. Role of surface charge in cytotoxicity of charged manganese ferrite nanoparticles towards macrophages. Nanotechnology 23(50), 505702 (2012
54. Xiao K, Li Y, Luo J et al. The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials 32(13), 3435-3446 (2011
55. He C, Hu Y, Yin L, Tang C, Yin C. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31(13), 3657-3666 (2010
56. Chithrani BD, Ghazani AA, Chan WC Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 6(4), 662-668 (2006
57. Nowacek AS, Balkundi S, Mcmillan J et al. Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, Drug release and antiviral activities in human monocyte-derived macrophages. J. Control. Release 150(2), 204-211 (2011
58. Banquy X, Suarez F, Argaw A et al. Effect of mechanical properties of hydrogel nanoparticles on macrophage cell uptake. Soft Matter 5, 3984-3991 (2009
59. Waite CL, Roth CM. Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: Current progress and opportunities. Crit. Rev. Biomed. Eng. 40(1), 21-41 (2012
60. Li L, Sun J, He Z. Deep penetration of nanoparticulate drug delivery systems into tumors: Challenges and solutions. Curr. Med. Chem. 20(23), 2881-2891 (2013
61. López-Dávila V, Seifalian AM, Loizidou M. Organic nanocarriers for cancer drug delivery. Curr. Opin. Pharmacol. 12(4), 414-419 (2012
62. Keliher EJ, Yoo J, Nahrendorf M et al. 89Zr-labeled dextran nanoparticles allow in vivo macrophage imaging. Bioconjug. Chem. 22(12), 2383-2389 (2011
63. Needham LA, Davidson AH, Bawden LJ et al. Drug targeting to monocytes and macrophages using esterase-sensitive chemical motifs. J. Pharmacol. Exp. Ther. 339(1), 132-142 (2011
64. Jain NK, Mishra V, Mehra NK. Targeted drug delivery to macrophages. Expert Opin. Drug Deliv. 10(3), 353-367 (2013
65. Batrakova EV, Gendelman HE, Kabanov AV. Cell-mediated drug delivery. Expert Opin. Drug Deliv. 8(4), 415-433 (2011
66. Gunaseelan S, Gunaseelan K, Deshmukh M, Zhang X, Sinko PJ. Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs. Adv. Drug Deliv. Rev. 62(4-5), 518-531 (2010
67. Chao Y, Karmali PP, Simberg D. Role of carbohydrate receptors in the macrophage uptake of dextran-coated iron oxide nanoparticles. Adv. Exp. Med. Biol. 733, 115-123 (2012
68. Luo Y, Zhou H, Krueger J et al. Targeting tumor-Associated macrophages as a novel strategy against breast cancer. J. Clin. Invest. 116(8), 2132-2141 (2006
69. Allavena P, Germano G, Belgiovine C, D'Incalci M, MantoVani A. Trabectedin: A drug from the sea that strikes tumor-Associated macrophages. Oncoimmunology 2(6), e24614 (2013
70. Movahedi K, Schoonooghe S, Laoui D et al. Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-Associated macrophages. Cancer Res. 72(16), 4165-4177 (2012
71. Zhu S, Niu M, O'Mary H, Cui Z. Targeting of tumorassociated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles. Mol. Pharm. 10(9), 3525-3350 (2013
72. Majeti R, Chao MP, Alizadeh AA et al. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell 138(2), 286-299 (2009
73. Rodriguez PL, Harada T, Christian DA, Pantano DA, Tsai RK, Discher DE. Minimal 'self ' peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles. Science 339(6122), 971-975 (2013
74. Xiang R, Luo Y, Niethammer AG, Reisfeld RA. Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis. Immunol. Rev. 222, 117-128 (2008
75. Huang Z, Zhang Z, Jiang Y et al. Targeted delivery of oligonucleotides into tumor-Associated macrophages for cancer immunotherapy. J. Control. Release 158(2), 286-292 (2012
76. Squadrito ML, Etzrodt M, De Palma M, Pittet MJ. MicroRNA-mediated control of macrophages and its implications for cancer. Trends Immunol. 34(7), 350-359 (2013
77. Chakraborty P, Chatterjee S, Ganguly A et al. Reprogramming of TAM toward proimmunogenic type through regulation of MAP kinases using a redox-Active copper chelate. J. Leukoc. Biol. 91(4), 609-619 (2012
78. Hagemann T, Lawrence T, McNeish I et al. 'Re-educating' tumor-Associated macrophages by targeting NF-kappaB. J. Exp. Med. 205(6), 1261-1268 (2008
79. Rogers TL, Holen I. Tumour macrophages as potential targets of bisphosphonates. J. Transl. Med. 9,177 (2011
80. Miselis NR, Wu ZJ, Van Rooijen N, Kane AB. Targeting tumor-Associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma. Mol. Cancer Ther. 7(4), 788-799 (2008
81. Zeisberger SM, Odermatt B, Marty C, Zehnder-Fjällman AH, Ballmer-Hofer K, Schwendener RA. Clodronateliposome-mediated depletion of tumour-Associated macrophages: A new and highly effective antiangiogenic therapy approach. Br. J. Cancer 95(3), 272-281 (2006